Mary Bell, LMFT in Choctaw, MS - Marriage & Family Therapist

Mary Bell, LMFT is a Marriage & Family Therapist based in Choctaw, Mississippi. Mary Bell is licensed to practice in Mississippi (license number T10696) and her current practice location is 114 Sunset Rdg, Choctaw, Mississippi. She can be reached at her office (for appointments etc.) via phone at (601) 780-0409.

NPI number for Mary Bell is 1063271963 and her current mailing address is 210 Hospital Cir, Choctaw, Mississippi. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1063271963.

Contact Information

	Mary Bell, LMFT
	114 Sunset Rdg, Choctaw, MS 39350-4567
	(601) 780-0409
	Not Available

Healthcare Provider's Profile

Full Name	Mary Bell
Gender	Female
Speciality	Marriage & Family Therapist
Location	114 Sunset Rdg, Choctaw, Mississippi
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1063271963
Provider Enumeration Date: 03/14/2024
Last Update Date: 03/14/2024

Medical Identifiers

Medical identifiers for Mary Bell such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1063271963	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
106H00000X	Marriage & Family Therapist	T10696 (Mississippi)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mary Bell is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mary Bell, LMFT 210 Hospital Cir, Choctaw, MS 39350-6781 Ph: (601) 389-4150	Mary Bell, LMFT 114 Sunset Rdg, Choctaw, MS 39350-4567 Ph: (601) 780-0409

News Archive

Soft drinks increase risk of developing pancreatic cancer

Consuming two or more soft drinks per week increased the risk of developing pancreatic cancer by nearly two-fold compared with individuals who did not consume soft drinks, according to a report in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

Delcath's second generation CHEMOSAT system receives European CE Mark

Delcath Systems, Inc. today announced that the Company has received CE Mark approval for the second generation hemofiltration cartridge of the Company's proprietary Hepatic CHEMOSAT Delivery System.

Deficit plans target politically-protected Medicare program

The politically-sacrosanct Medicare program is in the crosshairs of proposals to cut the deficit, prompting possible battles between seniors' advocates and debt-conscious lawmakers, Kaiser Health News reports.

Study of new gene and cell therapy to better understand how genetically-engineered cells can help pace the heart

Guidant Corporation, Columbia University and Stony Brook University will collaborate to study a new gene and cell therapy that may ultimately provide better understanding of how genetically-engineered cells can help pace the heart.

Ridaforolimus Phase III SUCCEED clinical trial on metastatic sarcoma meets primary endpoint

Merck, known outside the United States and Canada as MSD, and ARIAD Pharmaceuticals, Inc.,, today announced the presentation of detailed results from the Phase III SUCCEED clinical trial. SUCCEED evaluated oral ridaforolimus, an investigational mTOR inhibitor, in patients with metastatic soft-tissue or bone sarcomas who previously had a favorable response to chemotherapy.

Mary Bell, LMFT - Couples Therapy in Choctaw, MS